Government allows Serum Institute to export 50 lakh Covishield doses under COVAX to 4 nations
Highlights
- The SII will commence Covid vaccine export under the COVAX program from November 23.
- Nepal will receive the first lot of Covishield on November 24.
- The government, earlier in October, had permitted the SII to export 10 lakh Covishield doses.
The Union government has allowed the Serum Institute of India to export 50 lakh doses of COVID-19 vaccine Covishield under the UN-backed COVAX global vaccine program to Nepal, Tajikistan, and Mozambique, official sources said on Sunday. In addition to these three countries, the SII will also export Covishield to Bangladesh under COVAX, they said.
The SII will commence Covid vaccine export under the COVAX program from November 23 and Nepal will receive the first lot of Covishield on November 24.
The government, earlier in October, had permitted the SII to export 10 lakh Covishield doses each to Nepal, Myanmar, and Bangladesh under the 'Vaccine Maitri' program.
In a recent communication to the Union Health Ministry, Prakash Kumar Singh, Director, Government, and Regulatory Affairs at Serum Institute of India (SII) are learned to have informed that the Pune-based firm has manufactured stock of 24,89,15,000 doses of Covishield and that the stock is increasing day by day.
